Flavonoid P-glycoprotein CYP3A4 Pregnane X receptor a b s t r a c t
Introduction
Paclitaxel was derived from the bark of the pacific yew tree (Taxus brevifolia) and worldwide used as one of the most important anticancer drugs for the treatment of various tumors such as breast, ovarian and lung cancer [1, 2] . Until recently, paclitaxel is clinically formulated in a mixture of Cremophor EL and dehydrated ethanol for the intravenous infusion because its intestinal uptake is avidly hampered by transmembrane efflux transporter such as P-glycoprotein [3, 4] .
Since Cremophor EL itself could be toxic and the oral administration has many advantages over intravenous administration, oral paclitaxel formulation is still needed as a critical option for treating cancer [5] . Oral paclitaxel formulas have been tried for decades, including concomitant use of P-glycoprotein inhibitors, such as verapamil, tamoxifen, cyclosporine A [6e8]. In addition, paclitaxel is mainly metabolized by the liver, several studies have demonstrated that coadministration of CYP3A4 inhibitors could enhance the oral bioavailability of paclitaxel [9, 10] . However, no oral formula of paclitaxel has been approved by far. The use of those drugs is limited because the required concentrations to modulate P-gp and CYP3A could result in cardiac toxicity and other adverse effects [11] . Therefore, compounds that can inhibit P-gp and CYP3A4 activity with low toxicity are highly desired to increase the systemic exposure of paclitaxel. Taxus yunnanensis Cheng et L.K. Fu, which belongs to the plant family Taxaceae is widely distributed in south China. The branches, leaves and seeds of this plant have been used in traditional Chinese medicine for the treatment of kidney problem and diabetic conditions. In recent years, T. yunnanensis has been exploited a lot for its high content of paclitaxel. Meanwhile, many other components except for paclitaxel found in T. yunnanensis were shown biological activities [12, 13] .
Our previous pharmacokinetic results showed that oral bioavailability of paclitaxel was elevated by 10 times while the whole extract derived from T. yunnanensis containing paclitaxel was orally administrated to rats. Interestingly, flavonoid extract derived from T. yunnanensis was further confirmed to improve the oral bioavailability of paclitaxel (Data not show). According to our previous studies, flavonoids derived from T. yunnanensis might exert synergistic effect on paxlitaxel by affecting its pharmacokinetic behavior. However, the underlying mechanism is unclear yet. Many natural products have been widely reported to be able to increase the systemic exposure of paclitaxel by inhibiting the activity of P-glycoprotein and/or CYP3A [14e16] . Therefore, in this study, we investigated the effect of flavonoids derived from T. yunnanensis on P-gp and CYP3A4 to understand whether the flavonoids extract increased the systemic exposure of paclitaxel by inhibiting P-gp and/or CYP3A4.
2.
Materials and methods 
Extraction, isolation and analysis of flavonoids
Dried and pulverized barks and leaves of T. yunnanensis Cheng et L.K. Fu were extracted in back streaming apparatus with petroleum ether (b.p. 61 C) and 70% ethanol/water for 3 times. The ethanol/water extract was concentrated and dried in the evaporator. Flavonoids were chromatographed over Sephadex LH-20 column with ethanol and determined by HPLC-UV and UV. Chromatographic fingerprint analysis of flavonoids was performed on Shimadzu LC-20 UFLC system (Shimadzu, Tokyo, Japan) equipped with an LC-20AD pump, a SIL-20A autosampler, a CTO-20A oven and an SPD-M20A detector. The separation and analysis of flavonoids was performed on a C18 Column (250 mm Â 2.1 mm, 5 mm, Gemini, Phenomenex, USA) kept at 25 C. The mobile phases was consisted of methanol (A) and water (B) as following gradient programs at 1.0 ml/min: 0e30 min (30%e 60% A), 30e40 min (60%e80% A), 40e60 min (80% A), 60e65 min (80e100% A), 65e75 min (100% B), 75e80 min (100%e30% A), 80e90 min (30%). The eluent was monitored at wavelength of 190e600 nm. The injection volume for all samples was 20 ml.
Cell culture
Caco-2 cells were obtained from the American Type Culture Collection (Manassas, VA, USA). The cells were cultured in H-DMEM containing 10% FBS in a humidified atmosphere of 5% CO 2 at 37 C [17].
Isolation and culture of primary hepatocytes
The primary hepatocytes were isolated from C57 mice, which were supplied by the Laboratory Animal Service Center at Sun Yat-sen University (Guangzhou, China). Mouse was injected with 5 ml/g 0.7% chloralic hydras, and hepatic portal vein was perfused at 5 ml/min speed with digestion buffer to get excised liver. Then liver was cut up in the wash buffer and got through 100 Â mesh sheet. Hepatocytes were obtained after spinning 600 r/min and seeded into 12-well plates. The cells were cultured with daily change of media (Williams' E medium supplemented with L-glutamine, and fetal bovine serum), after 48 h, the hepatocytes were treated with media containing the test chemicals [18] .
2.5.
Detection of expression of P-gp and CYP3A4 by western blotting analysis P-gp expression was evaluated by western blot analysis in Caco-2 cells cultured for 48 h in presence or in absence of the flavonoid compounds. Caco-2 cells were digested in 0.25% trypsin and lysed for protein extraction. Protein concentrations of cells were determined using the lowry method [19] and bovine serum albumin as a standard. The protein sample (30 mg) was separated in 10% (w/v) SDS e polyacrylamide gel and blotted into a nitrocellulose membrane (Immobilon transfer membrane) at 250 mA for 90 min. The membranes were blocked for 2 h at room temperature in TBST containing 5% non-fat milk and then were incubated with P-gp antibody (1:500) or GAPDH (1:1000) overnight. Membranes were incubated with secondary antibody for 2 h. The protein bands were obtained from Gel image system. The expression of P-gp was a s i a n j o u r n a l o f p h a r m a c e u t i c a l s c i e n c e s 8 ( 2 0 1 3 ) 1 6 8 e1 7 3 normalized by that of GADPH. Cyp3a11 (CYP3A4 in human) expression was evaluated using mouse primary liver cell and incubated with anti-cyp3a11 antibody.
2.6.
Effect of flavonoids on P-gp activity Caco-2 cells were incubated in 37 C, 5% CO 2 flask for 1 week, and were further seeded into 96-well black plate with clear bottom at a density of 10,000 cells per well for 2 days. Then cells were treated with cyclosporine A (the positive control, 10 mM), vehicle (0.1% DMSO) and flavonoid components in three groups at concentrations of 0.5 mg/ml, 5 mg/ml and 50 mg/ 
Preparation of rat liver microsomes
Hepatic tissues were collected from healthy male Spra-gueeDawley rats (230e310 g). Liver microsomes were prepared as described previously, resuspended in 0.125 M KCl/0.01 M potassium phosphate, stored at À80 C, and used in one month [21] .
Effect of flavonoids on CYP3A4 activity
The liver microsomes (0.25 mg/ml) were incubated in presence or in absence of the flavonoid compounds at different concentrations for 30 min, midazolam (MDZ) was added and after 15 min tert-butyl methyl ether/dichloromethane (75:25, v/v) was added to stop metabolism of MDZ. CYP3A4 activity was evaluated by amount of the metabolite of MDZ: 1-OHmidazolam (1-OH-MDZ), which was detected by liquid chromatography/tandem mass spectrometry [22] .
Transient transfection and reporter gene assay
LS174T cells were seeded into 96-well plate and cultivated for 24 h. Transfection was performed in Phenol red-free RPMI 1640 medium supplemented with charcoal/dextran-treated FBS. The cells were transfected with 100 ng PSG5-PXR, 100 ng PGL3-CYP3A4-XREM-reporter, 5 ng PLR-TK as an internal control. 50 ng PSG5 was transfected instead of PSG5-PXR as vector control. After 6 h, cells were exposed to RIF at 10 mm, which is a known PXR transactivator, KTZ (25 mm, the positive control), and flavonoids at different concentrations (0.8, 4, 20, 100 mg/ml) for 24 h, the cells were harvested and analyzed for luciferase expression with a dual-luciferase reporter assay kit (Promega) [23] .
Results and discussion

Polychemistry analysis of extracts
The flavonoid extracts were obtained through fractionation of ethanol extract of T. yunnanensis using macroporous absorbent resin chromatography and HPLC analysis. As shown in Fig. 1 , chromatographic fingerprint analysis of flavonoids contained amentoflavone, bilobetin, 7-O-methylamentoflavone, ginkgetin, sciadopitysin.
Effects of flavonoids derived from T. yunnanensis on P-gp
Western bolt analysis was performed to observe the effect of flavonoid extracts on the expression of P-gp. As shown in Fig. 2 , expression of P-gp was only inhibited slightly as concentration of flavonoids was up to 50 mg/ml. Furthermore, intracellular rhodamine 123 accumulation assay was conducted using Caco-2 cells to investigate the effect of flavonoids on the activity of P-gp. Inhibition of P-gp activity leads to decrease of the efflux of intracellular rhodamine 123 and increase of fluorescence associated with intracellular rhodamine 123. After treatment with flavonoids for 1 h, fluorescence of intracellular rhodamine 123 increased to almost 1000 units comparing with 400 units in control group. To further study inhibitory effect of flavonoids on P-gp activity in long-term, Caco-2 cells were incubated with flavonoids for 48 h, the result showed that more rhodamine 123 was accumulated in cells and fluorescence of intracellular rhodamine 123 increased to more than 1500 units at concentration of 50 mg/ml (Fig. 3 ). Our results indicated that increase of intracellular rhodamine 123 by flavonoids was mainly through inhibiting P-gp activity but not protein expression. Interestingly, it should be noted that effects of the 5 flavonoids (see in Fig. 1) we identified from the extract on P-gp are still unclear, but this whole extract showed inhibitory effect on P-gp activity, which might be a kind of combined effect of the components in the extract.
3.3.
Effects of flavonoids derived from T. yunnanensis on CYP3A4 Cytochrome P450 (CYPs) are the principal enzymes for oxidative metabolism of drugs and other xenobiotics. In human liver microsomes, CYP3A4 is the most abundant enzyme, and more than 50% of drugs (including paclitaxel) clinically used are oxidized by CYP3A4. Therefore, we further studied the effect of the flavonoid extract on the expression of CYP3A4 (cyp3a11 in mouse) using mouse primary hepatocytes. Fig. 4 showed that expression of cyp3a11 was markedly decreased in cells incubated with flavonoid extract for 48 h, and protein expression of cyp3a11 was reduced in a concentration dependent manner. To further investigate the effect of flavonoid extract on the activity of CYP3A4, 1-OH-midazolam, the metabolite of typical CYP3A4 substrate of midazolam, was measured by our previously reported LC-MS/MS method after incubation with rat liver microsomes. After treatment with different concentrations of flavonoid extracts, the activity of CYP3A was dramatically inhibited in a concentration-dependent manner (P < 0.01) ( Fig. 5 ).
It has been reported that flavonoid intake could enhance the bioavailability of some orally administered drugs [24, 25] . In our previous studies, the bioavailability of paclitaxel was significantly enhanced by T. yunnanensis extract. As mentioned above, paclitaxel is a substrate of P-gp and is mainly metabolized by hepatic CYP3A, the pharmacokinetic interaction of paclitaxel may be attributed not only to the modulation of P-gp but also to CYP3A4. However, sometimes it is difficult to distinguish between the effect on P-gp or in CYP3A4 in vivo. Our in vitro study showed that flavonoids extract from T. yunnanensis significantly reduced expression of CYP3A and concurrently inhibited activity of CYP3A4. In addition, amentoflavone isolated from Ginkgo biloba has been reported to show a strong inhibitory effect on CYP3A4 [26] , we supposed that amentoflavone might be the main inhibitory factor on CYP3A4 in the current flavonoid extract.
3.4.
Inhibitory effects of flavonoids derived from T. yunnanensis on CYP3A4 expression through PXR-CYP3A4 pathway Pregnane X receptor (PXR) is an important determinant of xenobiotics-induced CYP3A4 expression. To determine whether inhibition of CYP3A4 protein expression was regulated by PXR pathway, an in vitro PXR activation assay using a luciferase receptor was performed. Flavonoids were tested in the human PXR reporter gene system at the concentrations ranging from 0 to 100 mg/ml. As shown in Fig. 6 , compared to the control group, RIF significantly induced CYP3A4 luciferase activity to 3.34-fold in transiently transfected LS174T cells (P < 0.01), and the induction by RIF markedly decreased while the transfected cells were co-treated with flavonoids and RIF. The result indicated that flavonoids inhibited gene expression of CYP3A4 through modulation of PXR pathway.
Conclusion
In the present study, flavonoid extract was derived from T. yunnanensis and was investigated to show inhibitory effects on both P-gp and CYP3A4, and gene expression of CYP3A4 was modulated through PXR pathway. Since paclitaxel is the substrate of P-gp and CYP3A4 and it also can be obtained from T. yunnanensis, our results suggested that flavonoid extract derived from T. yunnanensis might provide a pharmacokinetic benefit for development of oral paclitaxel formulation. 
